Past Events

  • Clinical trial opens enrollment: shifting the PARADIGM with PrimeC
    Nov 30, 7:00 PM
    Zoom call
    Prior to the establishment of NeuroSense, Alon founded MediCan Consulting, a successful consultancy firm which worked and collaborated with many leading pharmaceutical R&D companies, including Mediwound, Chiasma, Teva, Sol-Gel, FutuRx, NeuroDerm and others
  • ALS Reversals: An Update for 2022
    Nov 23, 7:00 PM
    Zoom call
    Dr. Richard Bedlack grew up in a small town in central Connecticut. He went to college at William and Mary in Virginia, then back to Connecticut for an MD and Ph.D. in Neuroscience at UConn. Finally, he came to Duke where he completed his Medicine Internship, Neurology Residency, Neuromuscular Fello
  • BCI and ALS - Augmented Reality for people with ALS
    Nov 09, 7:00 PM
    Zoom call
    Dr. Heiman-Patterson is the Director of the Center for Neurodegenerative Disorders and a Professor in the Department of Neurology at the Lewis Katz School of Medicine at Temple University. She directs the MDA/ALS Center of Hope, including the clinical and laboratory research programs
  • Newsflash: Amylyx: RELYVRIO!
    Wed, Oct 26
    Zoom call
    Oct 26, 7:00 PM EDT
    Zoom call
    Dr. Paganoni is an Associate Professor at Harvard Medical School and works as a physician scientist at the Healey Center for ALS at Massachusetts General Hospital and at Spaulding Rehabilitation Hospital.Her research focuses on clinical trials and therapy development for ALS.
  • Telemedicine and You: Building Proactive, Personalized Care for all People with ALS
    Oct 12, 7:00 PM EDT
    Zoom call
    Telemedicine and You: Building Proactive, Personalized Care for all People with ALS with Brian Wallach, Dr. Eric Anderson, Dr. Danielle Geraldi, and Brook Croke.
  • Modulating Systemic Immunity as Treatment for ALS
    Sep 28, 7:00 PM EDT
    Zoom call
    Michael S. McGrath, MD, PhD – Chief Scientific Officer Neuvivo, Professor Department of Medicine, UCSF. Michael S. McGrath, MD, PhD is Professor, Departments of Laboratory Medicine, Pathology, and Medicine at The University of California San Francisco (UCSF). He has authored over 200 scientific art
  • Using induced pluripotent stem cells as a platform for understanding ALS disease mechanisms and therapeutic development
    Sep 14, 7:00 PM EDT
    Zoom call
    Dr. Maragakis is the Medical Director of the Johns Hopkins ALS Clinical Trials Unit and Director of the ALS Center for Cell Therapy and Regeneration Research and Professor of Neurology at Johns Hopkins University. The Center for ALS Specialty Care at Johns Hopkins is a world recognized leader in pro
  • Virtually bringing comfort & safety to your home
    Aug 31, 7:00 PM EDT
    Zoom call
    Homes are where we all live, work, play, and thrive. At Prev.ai, we believe that homes should grow with us, and just as our lives change, so should our homes. We are a 100% virtual fall prevention program harnessing computer vision and AI, linked to a network of trained clinicians, to provide person
  • Boosting Resiliency with Nicotinamide Riboside
    Aug 17, 7:00 PM EDT
    Zoom call
    Charles Brenner is the Alfred E Mann Family Foundation Chair in Diabetes and Cancer Metabolism in the Department of Diabetes & Cancer Metabolism. His laboratory focuses on disturbances in nicotinamide adenine dinucleotide (NAD), the central catalyst of metabolism, in diseases and conditions of met
  • NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study
    Aug 03, 7:00 PM
    Zoom call
    Prior to the establishment of NeuroSense, Alon founded MediCan Consulting, a successful consultancy firm which worked and collaborated with many leading pharmaceutical R&D companies, including Mediwound, Chiasma, Teva, Sol-Gel, FutuRx, NeuroDerm and others. The firm’s diligent employees were pioneer
  • How do we track ALS progression, and why does it matter
    Jul 20, 4:00 PM
    Zoom call
    Dr. Christina Fournier is an Associate Professor of Neurology at Emory University. She is the director of the Atlanta VA ALS Clinic, co-director of the Emory ALS Center, and Emory Neuromuscular Division director. Her clinical work is focused on the care of patients with ALS and neuromuscular disor
  • Technology for ALS Living and Voice Banking
    Jul 06, 4:00 PM
    Zoom Call
    Louisiana native Michael Holoway is a perfect addition to the Team Gleason Technology program. His experience in leadership, management and customer service is incredibly valuable for Team Gleason’s mission, but also critically important to the ALS community. In joining Team Gleason, Michael said, “
  • Findings from EverythingALS Studies
    Jun 22, 4:00 PM
    Zoom call
    In this episode of ALS Expert Talk, join us to learn about our Findings from EverythingALS Studies
  • ALS - Unmet Needs
    Wed, Jun 08
    Zoom Call
    Jun 08, 4:00 PM
    Zoom Call
    Our Speaker Professor Matthew Kiernan is the Brain and Mind Centre Co-Director - Discovery and Translation.
  •  The influence of infection and Inflammation in ALS
    May 25, 4:00 PM
    Zoom Call
    In this ALS Talk series, our speaker, MATTHEW S. MILLER PhD, Associate Professor, Biochemistry & Biomedical Sciences talk about Immunity, Virus, and the Role of Inflammation in ALS.
  • Moving from a few genes to a genetic architecture for ALS and the insights it provides
    May 11, 4:00 PM
    zoom call
    Michael Snyder, Ph.D. Moving from a few genes to a genetic architecture for ALS and the insights it provides Michael Snyder, Ph.D., Professor in Genetics Stanford University School of Medicine Bio: 977 B.A, Chemistry and Biology, University of Rochester, NY 1978-1982 Ph.D. California In
  • Augmentative communications program for ALS
    Apr 27, 4:00 PM PDT
    Zoom Call
    John Costello has been a speech-language pathologist at Boston Children's Hospital for 36 years where he directs the Augmentative Communication Program and the ALS Augmentative Communication Program.
  • New Gene Therapy for ALS
    Wed, Apr 13
    Zoom Call
    Apr 13, 4:00 PM PDT
    Zoom Call
    Dr. Ozdinler is an Associate Professor of Neurology at Northwestern University, Feinberg School of Medicine, focusing on understanding the biology and pathology of upper motor neurons.